Table 1.
Demographic, Tumor, and Treatment Characteristics of Patients presenting with localized ESOS who underwent definitive surgery (N=370)
|
Age (yrs) |
Median | 58 |
| Range | 19 – 88 | |
| Age (categorical) | 19 to 40 years | 61 (16.5) |
| 41 to 65 years | 184 (49.7) | |
| 65 years and older | 125 (33.8) | |
| Sex | Male (%) | 217 (58.6) |
| Female (%) | 153 (41.4) | |
| Depth of Tumour | Superficial (%) | 71 (19.2) |
| Deep (%) | 294 (79.5) | |
| Unknown (%) | 5 (1.3) | |
|
Maximal Diameter of Tumour (cm) 19 NAs |
Median | 8.5 |
| Range | 1 – 45 | |
|
Maximal Diameter (categorical) 19 NAs |
<= 5cm | 83 (23.6) |
| 5 to 10cm | 132 (37.6) | |
| > 10cm | 136 (38.7) | |
| Location of Tumour | Thigh | 182 (49.2) |
| Pelvis/Buttocks | 46 (12.4) | |
| Trunk | 42 (11.4) | |
| Shoulder/Arm | 38 (10.3) | |
| Leg | 29 (7.8) | |
| Elbow/Forearm | 14 (3.8) | |
| Knee | 9 (2.4) | |
| Ankle/Foot | 4 (1.1) | |
| Hand | 3 (0.8) | |
| Face | 3 (0.8) | |
| Radiation Therapy | No | 218 (58.9) |
| Yes | 152 (41.1) | |
| Chemotherapy | No | 190 (51.4) |
| Yes | 178 (48.1) | |
| Unknown | 2 (0.5) | |
| Type of Chemotherapy | “osteosarcoma-type”: methotrexate or cisplatin-based | 86 (48.3) |
| “STS-type”: no methotrexate or cisplatin | 58 (32.6) | |
| Other / Unknown | 34 (19.1) | |
| Adjuvant or Neoadjuvant Therapy | Neither Chemo nor Rads | 122 (33.0) |
| Chemo Only | 96 (25.9) | |
| Rads Only | 70 (18.9) | |
| Chemo and Rads | 82 (22.2) | |
| Type of Surgery | Limb Salvage | 345 (93.2) |
| Amputation | 25(6.8) | |
|
Margins 6 NAs |
Negative | 309 (84.9) |
| Micro + | 36 (9.9) | |
| Gross + | 19 (5.2) |
(NA = not available, STS=soft tissue sarcoma)